Navigation Links
Ossur Acquires the U.S. Orthopaedics Company

Iceland-based Ossur hf., a global orthopaedics company, has acquired Innovation Sports, Inc., a U.S.-based ligament brace maker for $ 38.4 million.

The acquisition of Innovation Sports comes on the heels of Ossur's July 2005 acquisition// of Royce Medical in the U.S., and the December 2005 acquisition of IMP Holdings in the U.K. With these acquisitions, and its 2003 acquisition of Generation II, Ossur aspires to be one of the world's largest, and diversified companies in the braces and support market.

Ossur president & CEO Jon Sigurdsson said Innovation Sports would give Ossur a leading edge in ligament braces, the largest segment of the braces and support market, and accelerate Ossur's strategic initiative to advance in the orthopaedics market with improved operating efficiencies and other synergies.

Innovation Sports, based in Foothill Ranch, California, established in 1983, has 150 employees with the U.S. (50% sales), Canada (10%) and central Europe (40%) as its main markets. The company specializes in the manufacture of knee braces for the treatment of ligament injuries and rehabilitative uses, as well as protective braces for athletes. It also has product lines that address pain management and wrist braces, which are new to the Ossur product portfolio.

For the fiscal year ending 31 December 2005, Innovation Sports is expecting sales of $19 million and a normalized EBITDA margin of 19%. In connection with the acquisition, Ossur expects to incur approximately $3 million of integration and restructuring expenses in 2006 fully expensed in Q1, but projects that these efforts will yield approximately $4 million of annual cost savings beginning in 2007.

In connection with the acquisition, additional funding of $40 million has been provided by Kaupting bank hf.

Ossur is a trusted and global leader in the development, manufacturing, distribution, sales and marketing of braces and support products and prosthetic s. Headquartered in Reykjavik, Iceland, the company has operations and a distribution network throughout the world.
'"/>




Related medicine news :

1. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
2. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
3. Premier Army Hospital Acquires PET-CT Scanner
4. Indoco Remedies Acquires La Nova Chem
5. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
6. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
7. Apollos Global Arm Acquires US-based Firm
8. ‘Obesity’ Acquires Permanent Resident Status in the US
9. Indias Wockhardt Acquires Irish Firm
10. Battle against Gum Disease Acquires new Weapon
11. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: